Bengt Ågerup
Bengt is a Ph D and has held senior positions within Pharmacia and Biomatrix and started the company Q-Med that was subsequently sold to Galderma in 2011. Q-Med is the world leading company for dermal injectable fillers and the main product is Restylane. Bengt is the Chairman of Stockholm Uppsala Life Science and a Board Member of the Swedish Foundation for Strategic Research.

Anders Blom
Anders has most recently spent ten years at Q-Med, first as Corporate- and Business Controller but during the last 6 years he worked as Senior Director Corporate Development and Strategy. He has also worked as Business Controller in the EMEA region for Pharmacia Corp. and as auditor at the Swedish tax authorities (Skatteverket). Anders has a Bachelor of Science in Business Administration from Uppsala University. 

Kristin Ermanbriks
Kristin is Project Co-ordinator in NXT2B. She has been with Q-Med as Manager Corporate Administration and held Executive Assistant positions within Conpharm and the Department of Otolaryngology and Head & Neck Surgery, Uppsala University. Kristin has also worked as Marketing Assistant for different geographical areas at Pharmacia International.

Jon Heimer
Jon Heimer has 20 years of experience in developing and commercializing medical devices and pharmaceutical/biotech products. Jon is joining NXT2B from OxThera where he served as CEO since 2005, prior to that responsible for product and business development at Q-Med. Jon is an entrepreneur with a formal background in Economics from Uppsala University and Marketing from Eductus Business School in Sweden. 

Erika Kjellberg Eriksson
Erika has been working in the life science sector for 15 years. Before joining nxt2b she served as CFO of OxThera, prior to that as Vice president and CFO of Q-Med and as CFO and CEO of BioPhausia. She has also been a board member of Bluefish Pharmaceuticals and A+ Science. Erika has a formal background as B.Sc. in Ba and Econ. from Uppsala University and started her career as an auditor at Ernst & Young. 

Alexander Kotsinas
Alexander has a Master of Science from the Royal Institute of Technology in Applied Physics and a Bachelor of Science from Handelshögskolan in Stockholm. Prior to joining NXT2B Alexander served as Vice President and CFO of Q-Med AB. Alexander has also served as CFO of Life Europe AB and 3 Scandinavia. Alexander has also worked at Investor AB and Ericsson. 

Olle Kämpe
Scientific adviser part-time. Professor of Molecular Medicine at  Uppsala University since 1999 and senior consultant in internal  medicine and in endocrinology at the University Hospital in Uppsala.  Elected fellow of the Royal Swedish Academy of Sciences 2011.